Skip to Main
Covid 19

Inovio COVID-19 Vaccine Trials Put on Hold for FDA Questioning

Another pharmaceutical company has hit a speedbump in the race to come up with a coronavirus vaccine.

Inovio Pharmaceuticals says its phase two and three trials are on hold as it responds to additional questions from the FDA.

The bio-tech company says the pause is not due to any adverse reactions.

Inovio says once it responds, health officials have 30 days to decide whether its trial can continue.

Local Trending News